Table 2.
Risk factors of infection with COVID-19 in the Study Population.
| Variables | N | Positive PCR n(%) | ORa | 95%CI | p-Value |
|---|---|---|---|---|---|
| Age range (year) | |||||
| [18–21] | 81 | 15 (18.52) | Ref | ||
| [21–24] | 120 | 31 (25.83) | 1.81 | 0.8–3.7 | 0.11 |
| [24–28] | 90 | 16 (17.78) | 1.09 | 0.4–2.5 | 0.83 |
| Sexe | |||||
| Female | 153 | 44 (28.76) | Ref | ||
| Male | 138 | 18 (13.04) | 2.21 | 1.5–4.5 | 0.0007 |
| Location | |||||
| Bangangte | 198 | 50 (25.25) | Ref | ||
| Yaounde | 93 | 12 (12.90) | 1.95 | 1.2–3.8 | 0.01 |
| Clinical status | |||||
| Asymptomatic | 234 | 53 (22.65) | Ref | ||
| Symptomatic | 57 | 9 (15.79) | 0.64 | 0.3–1.4 | 0.2 |
| Comorbidities | |||||
| No | 279 | 58 (20.79) | Ref | ||
| Yes | 12 | 4 (33.33) | 1.14 | 0.3–4.3 | 0.84 |
| Case-contact | |||||
| No | 235 | 52 (22.13) | Ref | ||
| Yes | 56 | 10 (17.86) | 0.61 | 0.3–1.4 | 0.25 |
| Nomadic | |||||
| No | 271 | 57 (21.03) | Ref | ||
| Yes | 20 | 5 (25) | 1.82 | 0.5–6.1 | 0.33 |
| Treatment | |||||
| No | 287 | 61 (21.25) | Ref | ||
| Yes | 4 | 1 (25) | 1.70 | 0.15–18.7 | 0.66 |
PCR = Polymerase Chain Reaction; ORa = Adjusted Odds Ratio.